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SUMMARY 
 
Type 2 immunity at mucosal surfaces is thought to be initiated by type 2 innate 
lymphoid cells (ILC2s). New studies report that ILC2s are themselves activated 
by the neuropeptide neuromedin U (NMU), produced by cholinergic neurons in 
the gut and airways. 
 
 
  
Type 2 immunity is the arm of the immune system typically associated with both 
allergy, and effective defense against helminth worm infections [1, 2]. Type 2 cells 
release a range of soluble multifaceted effector cytokines, accelerating intestinal 
nematode expulsion and wound repair, but also exacerbating disease in allergic 
patients when dysregulated. At the heart of type-2 immunity are two different 
lymphoid–derived cells; T helper type-2 (Th2) cells of the adaptive immune axis, that 
release cytokines when activated through their antigen-specific receptors, and their 
mirror image in the innate immune system, type-2 innate lymphoid (ILC2) cells, 
representing potent first-responders to generic immune stimuli released at barrier 
surfaces [2, 3]. 
 
ILC2s are local amplifiers of the type-2 immune response, releasing the key cytokine 
drivers of eosinophil infiltration (IL-5), goblet and tuft cell hyperplasia (IL-13) and 
fibrosis, in response to signals such as alarmins secreted by epithelial cells [4]. 
Attention has focused on a troika of epithelial alarmins, namely IL-33, a DNA-
associated cytokine released upon cell damage; IL-25, produced by tuft cells in a 
taste-receptor signaling-dependent manner, and Thymic Stromal Lymphopoietin 
(TSLP), a predominant ILC2 activator in the skin [4, 5]. These mediators have been 
depicted in a simple bi-directional stromal cell/immune cell dialogue, that allows 
epithelial cells to flag and report an immune insult to ILCs, which in turn instruct the 
epithelial barrier to condition itself against the immediate challenge, while kick-
starting adaptive immunity to counteract chronic infections. A more profound network 
is now revealed by three novel reports [6-8] introducing a multidirectional 
communication circuit between stromal, immune system and nerve cells in which 
ILC2s are the central cell type coordinating the crosstalk between the mucosa and 
the innervation (Figure 1a). In this system, it is the release of the peptide 
neuromedin U (NMU) by cholinergic neurons [7, 8] which is the key event in ILC 
activation, showing that type 2 immunity is not dictated exclusively by epithelial cells.  
 
NMU is a neuropeptide, 25 amino acids in length in the human. It is a potent activator 
of two NMU receptors (NMUR), of which Nmur1 is specifically expressed by ILC2 
cells in the lung and small intestine [6-8], but only marginally [8] in other lymphoid 
and myeloid populations, suggesting ILC2s are selectively responsive to the 
neuropeptide. ILC2-specific Nmur1 expression rises following either infection with the 
gastrointestinal helminth Nippostrongylus brasiliensis or intranasal allergen challenge 
[6-8], concomitant with increased NMU expression in helminth-infected intestinal and 
lung tissue [7, 8]. In particular, increased Nmur1 expression correlated with the 
expression of the IL-33 receptor (ST2), but not the IL-25 receptor [6], suggesting that 
Nmur1 may discriminate between subsets of alarmin-responsive ILCs. Additionally, 
IL-33 stimulation results in Nmur1 down-regulation, thereby limiting NMU action on 
ILCs following alarmin release. These data highlight a conserved mechanism of 
nerve–ILC2 crosstalk in diverse settings of type-2 pathophysiology, with its own 
intricate selectivity and regulation. 
 
A fascinating insight from these new studies is the intimate anatomical connection 
between the neuronal and innate lymphoid cells (Figure 1a). The closer proximity 
between the innervation of the intestinal lamina propria and lung parenchyma and 
resident ILC2 cells in comparison to T cells, leads to several interesting, but yet 
unanswered, questions regarding the function of this co-localization. Does NMU 
enjoy a very limited range of spatial activity within tissues, and are ILCs instructed by 
nerve-derived NMU to migrate from the fixed sites of enteric innervation, and/or do 
they do so in response to the epithelial alarmins? In fact, in an ex vivo assay of ILC2 
cell stimulation, NMU proved considerably more potent in promoting ILC2 cytokine 
production than either IL-25 or IL-33 [8] or even a combination of both [7]. However, 
the physiological NMU concentration inside the lamina propria or lung tissue has yet 
to be elucidated, and the degree of redundancy among the various ILC2 stimuli in 
vivo may be very considerable. Certainly, bone marrow chimera experiments testing 
both Nmur1-sufficient and -deficient cells showed a reduced but not abrogated type-2 
cytokine expression in lung Nmur1-deficient ILCs, demonstrating that no one ligand 
fulills a unique and indispensible role [8]. 
 
The significance of ILC2s was initially established in the setting of helminth infection, 
and hence it is not surprising that these parasites elicit increased NMU production in 
murine gut tissue [7]. Cardoso et al. and Klose et al. focused their in vivo 
characterization on ILC2-neuronal crosstalk (Figure 1b) during infection with N. 
brasiliensis, which migrates through, and induces strong type-2 immunity within, both 
the lung and the small intestine. Nmur1-deficient mice show increased worm burdens 
at early times points (days 2-7) in both tissues, alongside compromised type-2 
cytokine levels, airway eosinophilia and mast cell recruitment [7, 8]. However, N. 
brasiliensis was still effectively expelled by day 9 p.i. [8], emphasising again that the 
immune system can compensate, albeit tardily, through redundant mechanisms. As 
both lung and gut immunity is attenuated in Nmur1-deficient mice, it was not clear if 
delayed explusion is a result of impeded type-2 immune mechanisms in the lung or a  
consequence of malfunctional intestinal immunity. To circumvent this issue, Klose et 
al i.p. injected NMU days 2, 4 and 6 p.i., leading to a mildly, but significantly, reduced 
worm count at day 7 p.i., suggesting that intestinal NMU may indeed affect nematode 
survival. As NMU can also provoke intestinal smooth muscle contraction [9] which is 
instrumental in helminth expulsion [10], it was also important that to pinpoint the role 
of haematopoietic cells. Thus, both investigators injected bone marrow from Nmur1+/+ 
and Nmur-/- mice into alymphoid Rag2-/- Il2rg-/- mice. Worm burdens were augmented 
in Nmur-/- bone marrow chimeras compared to mice reconstituted with Nmur1-
sufficient cells [7, 8], emphasizing the importance of NMU-activated ILC2s in anti-
helminth immunity. 
 
To test the function of neuronal NMU release into the respiratory system outwith 
infection, two approaches were taken, with direct intranasal administration of NMU 
[7] and intranasal instillation of the highly allergenic house dust mite (HDM) extract 
[6]. In the lung, NMU proved to strongly induce ILC2 cytokine production and 
eosinophil recruitment, including in ILC2-reconstituted Rag2-/- Il2rg-/- mice [7]. In an 
elegant single cell RNA sequencing (scRNAseq) approach Wallrapp et al addressed 
the heterogeneity of ILC2 cells in resting, epithelial cytokine stimulated and HDM-
treated immune states. Strikingly, IL-25 and IL-33 induced different transcriptional 
profiles in ILC2s, with high Nmur1 expression at steady state and after IL-25 
treatment, but downregulated by IL-33. In particular, NMU amplifies the pro-
inflammatory capacity of IL-25, not only in vitro, but also in vivo when pulmonary 
pathophysiology is evaluated. In the allergic setting, however, Nmur1 deficiency 
resulted only in minor differences in terms of immunological readouts, other than the 
phenotype of ILC2s themselves. Despite reduced ILC2 cells and cytokines in Nmu 
KO mice after HDM challenge, this had no effect on the increased level total 
inflammation and augmented eosinophilic infiltration, which may be explained by 
compensatory CD4+ T-cell recruitment to the site of inflammation. Similarly when 
exposed to HDM, Nmur1 deficient mice only showed a mildly but significantly 
improved inflammatory score compared to WT mice  [6].  
 
By opening a new window into the generation of type 2 immunity, the authors also 
provoke many further questions. For example, the nature of the molecular patterns 
from helminths or allergens which select the type 2 pathway remain unresolved [11, 
12]. Interestingly, the secretions of N. brasiliensis (termed NES, previously reported 
to drive type 2 responses in vivo [13]) elicit NMU production from neurons indicating 
a pathogen recognition system in these cells. Direct neuronal sensing of microbial 
products has also been reported, most recently in an intestinal organ culture model 
[14]. Certainly, MyD88 (which also transduces the IL-33 signal) is required within 
neuronal cells for optimal immunity, implying that there may be a positive feedback 
loop in which NMU production is amplified by IL-33 or other epithelial/ILC2-derived 
signals [8] (Figure 1b). Equally, although mast cell- and eosinophil-deficient mice 
show intact NMU-driven ILC2 activation [7], it is known that these and other innate 
populations do participate in a fully orchestrated type 2 response to attack 
(appropriately) helminths and (inappropriately) allergens, and their interaction with 
neuronal cells seems highly likely. 
 
These exciting papers open up a new dimension in the immunological network, and 
add to growing appreciation of how pivotal the nervous system may be in driving the 
immune system [15, 16]. NMU is one of many small molecule mediators that act on 
immune cells, including vasoactive intestinal peptide (VIP) which regulates a 
circadian ILC-eosinophil interaction [17] and acetylcholine (ACh) produced by the 
NMU-producing neurons in the intestine [7]. Interestingly, ACh signaling is known to 
be required for immunity to N. brasiliensis [18]. Returning the compliment, many 
immune cells produce neuroactive molecules including ACh [19], histamine, 
serotonin and catecholamines [20], which in the latter case enable alternatively-
activated macrophages to regulate thermogenesis. While the full circuitry has yet to 
be mapped, it is clear that the integration of neuro-immune signaling will reveal many 
more critical interactions that will aid understanding of neuroimmunology and our 
ability to regulate immune dysfunction through neurological pathways. 
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Figure Legend 
 
Figure 1 
 
Type-2 innate lymphoid cells (ILC2s) and nerve cells form a neuro-
immunological unit within mucosal tissues.  
(a) The intestine is innervated by both sympathetic and parasympathetic nerves and 
is thereby connected to the central nervous system, but also encompasses an 
independent neurological network, the enteric nervous system (ENS). Nerve cells of 
the ENS, which extend into the villi, are organized in interconnected enteric ganglia 
forming submucosal and myenteric plexuses inbetween the intestinal muscle layers  
[15, 16]. In very close proximity to enteric neurons are ILC2 cells, innate immune 
cells capable of releasing type-2 cytokines in response to immune challenges and 
poised to be instructed by both neurological and epithelial mediators. Similarly, but 
not shown in the figure, ILC2s have been shown to be located close to neurons of 
the pulmonary innervation.  
(b) In the mucosa, ILC2s, epithelial cells and neurons form a neuro-immunological 
triangle, in which ILC2s resemble central effector cells instructed by both epithelial 
cytokines, e.g. IL-25 and the neuron-derived peptide NMU to release type-2 
cytokines in response to an immune challenge such as helminth infection, resulting in 
epithelial conditioning and amplification of local type-2 immunity. New evidence 
suggests the NMU release might be regulated directly by helminth-derived products, 
as well as epithelial cytokines and - possibly - type 2 cytokines from ILCs.   
 
 
 
 
 
